IGF-1 occupies a unique position in the body's hormonal architecture; it is both the primary mediator of growth hormone's anabolic effects and an independent signaling molecule with its own receptors and pathways throughout the body. While growth hormone stimulates the liver to produce IGF-1, injectable IGF-1 bypasses this requirement entirely, acting directly on target tissues without the need for upstream GH stimulation. This makes it particularly relevant for patients whose GH-to-IGF-1 conversion is compromised by age, liver function, or other factors that reduce the efficiency of the natural GH axis.
IGF-1's effect on body composition operates through protein synthesis regulation and fat metabolism support. It activates pathways that support the maintenance and integrity of lean tissue at the cellular level, particularly during caloric restriction or periods of physiological stress when the body would otherwise catabolize tissue for energy. Simultaneously, IGF-1 promotes the utilization of stored fat as fuel and supports insulin receptor sensitivity, contributing to healthier metabolic partitioning between fat storage and energy expenditure.
Bone health is one of IGF-1's most clinically documented secondary functions. IGF-1 receptors on osteoblasts; the cells responsible for bone formation; respond to IGF-1 stimulation by increasing bone matrix synthesis and mineralization. IGF-1 also supports collagen production in bone tissue and the regulation of the bone remodeling cycle that maintains skeletal density over time. These effects are relevant not only for patients concerned with age-related bone loss but for anyone seeking to support the structural foundation of long-term physical health.
IGF-1 crosses the blood-brain barrier and exerts neuroprotective effects within the central nervous system. It supports neurogenesis in the hippocampus, promotes myelination of nerve fibers, and protects neurons from oxidative and metabolic stress. Research links adequate IGF-1 levels to cognitive performance, processing speed, and neurological resilience; declining IGF-1 is associated with the same cognitive changes that accompany GH decline in aging.
IGF-1 also supports vascular endothelial growth factor (VEGF) expression and endothelial cell integrity; contributing to cardiovascular function, wound healing, and the maintenance of vascular health throughout the body.
At RegenMD, IGF-1 is administered as a subcutaneous injection five evenings per week over a five or ten-week program. Your provider establishes dosing based on your hormonal profile and wellness objectives and monitors your response throughout.
What This Means For You
- Promotes healthy body composition and lean tissue integrity
- Strengthens bone density and skeletal health
- Enhances cognitive function and neuroprotection
- Promotes healthy aging through tissue maintenance
- Fortifies vascular endothelial health
- Optimizes fat metabolism and energy utilization
- Encourages healthy blood sugar regulation
Also find IGF-1 in: Define Stack